Pricing Log in Create free account
Saturday 17 October 2026 Export GILD’s income statement to Excel — free account

Gilead Sciences, Inc.

GILD Healthcare Drug Manufacturers General

Gilead Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $29.4 billion, up 2.40% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS fell 638.2%, free cash flow grew 376.8% and total debt rose 5.21%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; dividend growth for ten consecutive years.

156.19 1.18 −0.75%
Market cap
$195.1B
P/E
0.0×
Fwd P/E
−46.2×
Dividend yield
2.08%
F-score
8/9
Altman Z
4.03
Beneish M
−2.45
Dividend safety
77/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Gilead Sciences, Inc. (GILD) Current ratio

Alert me on Current ratio

Gilead Sciences, Inc.'s current ratio at the end of the quarter to 30 June 2026 was 1.3×, down 0.3× from fiscal 2025 (1.6×). Over the past ten years it has ranged from 1.3× (fiscal 2021) to 3.4× (fiscal 2018); the current reading is higher than 45% of that period. That is in line with the Drug Manufacturers General industry median of 1.3× and below the Healthcare sector median of 3.0×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 1.6× (2.79%)
FY2024 1.6× 12.01%
FY2023 1.4× 10.95%
FY2022 1.3× 1.01%
FY2021 1.3× (9.34%)
FY2020 1.4× (54.79%)
FY2019 3.1× (8.13%)
FY2018 3.4× 23.55%
FY2017 2.7× 28.71%
FY2016 2.1× (15.13%)

Quarterly newest first

Period Current ratio Change
Jun 2026 1.3× (35.68%)
Mar 2026 2.0× 26.70%
Dec 2025 1.6× 6.83%
Sep 2025 1.5× 10.49%
42 more quarters

Against its own ten years

Low 1.3× High 3.4×
Ten-year median 1.6×
Current reading's percentile 45

Current ratio against peers

Company Current ratio
BMY Bristol Myers Squibb Company compare 1.5×
AMGN Amgen Inc. compare 1.4×
MRK Merck & Co., Inc. compare 1.3×
PFE Pfizer Inc. compare 1.3×
GILD Gilead Sciences, Inc. 1.3×
AZN AstraZeneca PLC compare 0.9×
NVO Novo Nordisk A/S compare 0.9×
NVS Novartis AG compare 0.9×
GSK GSK PLC Sponsored ADR compare 0.8×
Drug Manufacturers General industry median 1.3×
Healthcare sector median 3.0×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on GILD